Drug intelligence / Profile preview

Signature Cord Prime

Development stage
Phase 1
Lead developer
Arugula Sciences
Modality
Cell Therapies
Administration
Intraarticular
01

Overview

Signature Cord Prime is a cryopreserved, micronized human umbilical cord tissue allograft developed by Signature Biologics for the management of symptomatic knee osteoarthritis. Classified as a human cell and tissue-based product (HCT/P), it contains a complex array of naturally occurring biological components, including cellular growth factors, pro-angiogenesis factors, anti-inflammatory cytokines, and extracellular matrix components. The product is designed to modulate the intra-articular environment to reduce inflammation, improve joint function, and provide cartilage protection. It is administered via ultrasound-guided intra-articular injection and received FDA Investigational New Drug (IND) approval in February 2021 to proceed with Phase 1 clinical trials.

Brand names
Signature Cord Prime
Other names
SIG001SIG-001SIG 001

Beyond the preview

Go deeper on Signature Cord Prime.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signature Cord Prime.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call